Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes

The optimal osteoanabolic strategy in denosumab (Dmab)-users remains uncertain. In treatment-naïve patients, Dmab/teriparatide (TPTD) combinations result in dramatic bone mineral density (BMD) gains at the spine and hip. However, BMD outcomes with combination Dmab/TPTD have not been investigated in...

Descripció completa

Dades bibliogràfiques

Autors principals:	Shejil KUMAR, Courtney STREETER, Michelle M. MCDONALD, Roderick J. CLIFTON- BLIGH, Matti L. GILD, Christian M. GIRGIS
Format:	Artigo
Idioma:	Inglês
Publicat:	Elsevier 2025-06-01
Col·lecció:	Bone Reports
Matèries:	Teriparatide Denosumab Osteoporosis Bone mineral density Combination Sequence
Accés en línia:	http://www.sciencedirect.com/science/article/pii/S2352187225000245
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!